MRSN
Mersana Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MRSN fundamentals
Mersana Therapeutics (MRSN) released its earnings on Nov 14, 2025: revenue was 11.00M (YoY -12.68%), missed estimates; EPS was -1.51 (YoY -1577.78%), missed estimates.
Revenue / YoY
11.00M
-12.68%
EPS / YoY
-1.51
-1577.78%
Report date
Nov 14, 2025
Earnings Call
8:00 AM on Nov 14, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
MRSN has released its 2025 Q3 earnings report, with revenue of 11.01M, reflecting a YoY change of -12.61%, and net profit of -7.54M, showing a YoY change of 34.40%. The Sankey diagram below clearly presents MRSN's revenue sources and cost distribution.
Key Indicators
Mersana Therapeutics (MRSN) key financial stats and ratios, covering profitability, financial health, and leverage.
Mersana Therapeutics (MRSN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Mersana Therapeutics (MRSN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Mersana Therapeutics (MRSN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Mersana Therapeutics (MRSN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Mersana Therapeutics (MRSN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Mersana Therapeutics’s earnings call?What is Mersana Therapeutics's gross profit margin?Did Mersana Therapeutics beat or miss consensus estimates last quarter?What is Mersana Therapeutics's latest dividend and current dividend yield?What does Mersana Therapeutics do and what are its main business segments?What guidance did Mersana Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Mersana Therapeutics next quarter?What were the key takeaways from Mersana Therapeutics's earnings call?
